Meeting
Abstract Number: A8
SHM Converge 2022
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as the presence of ≥5% of hepatic steatosis (HS) in the absence of other liver disorders, such as chronic viral or autoimmune hepatitis, steatosis induced by drugs, significant alcohol consumption, hemochromatosis, or Wilson’s disease. There is limited literature describing national prevalence and epidemiological characteristics of NAFLD in […]
Abstract Number: 462
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Wilson Disease (WD) is a known cause of liver test abnormalities. Guidelines have been established to help clinicians avoid routine testing. According to the American Association for the Study of Liver Diseases (AASLD) Guideline, screening for WD—with serum ceruloplasmin, 24-hour urinary copper excretion, and slit-lamp examination for Kayser-Fleischer rings—is warranted in any patient with […]
Abstract Number: 584
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 47- year-old man with a history of hypothyroidism presented to the emergency room (ER) for the evaluation of generalized body weakness and jaundice of a week duration. There was also associated intense generalized pruritus of about 6 months; subjective weight loss, recurrent fevers, nausea and vomiting. Physical examination was significant for an […]
Abstract Number: 620
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: 53 year old male with a history of alcohol abuse presented to the ED with hyponatremia and elevated LFTs after a week of nausea, vomiting, and diarrhea. The patient had a previous drinking history of a 12-pack of beer per day, denied IV drug use and any recent travel outside of Texas. Determined […]